A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)
NCT05606614
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Rett Syndrome
Interventions
GENETIC:
TSHA-102
Sponsor
Taysha Gene Therapies, Inc.